Dr. Krem discusses age-related and biological factors for low-grade lymphoma pathogenesis and outcomes. He then explains the mechanisms of action from low-grade lymphoma therapies.  He finishes by applying recent efficacy and toxicity data to older patients with low-grade lymphoma.

Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page.

Disclaimers

©2015 LouisvilleLectures.org